Antibiotic Used on Drug-Eluting Stents May Lead to Advances in Heart Disease and Cancer Treatment, Louisiana State University Study
4/15/2010 6:58:41 AM
ScienceDaily (Apr. 15, 2010) — Research led by T. Cooper Woods, PhD, Assistant Professor of Pharmacology and Experimental Therapeutics at LSU Health Sciences Center New Orleans, and Director of the Molecular Cardiology Research Laboratory at Ochsner Clinic Foundation, has identified the mechanism of how a drug commonly used on stents to prevent reclosure of coronary arteries, regulates cell movement which is critical to wound healing and the progression of diseases like cancer.
comments powered by